Uganda's Ministry of Health and WHO have initiated the world's first randomized vaccine trial for Ebola Sudan virus, launching in record time just four days after outbreak confirmation.
The rVSV-ZEBOV Ebola vaccine, known as Ervebo, has demonstrated near-perfect efficacy in clinical trials, offering hope in combating the Zaire Ebola virus strain.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.